The influence of type 2 diabetes mellitus on the expression of inflammatory mediators and tissue inhibitor of metalloproteinases-2 in human chronic periodontitis

키워드

참고문헌 (36)

1. Engelgau MM, "The evolving diabetes burden in the United States", Ann Intern Med, 140, pp.945~950 (2004)
2. Fong DS, "Diabetic retinopathy", Diabetes Care, 26, pp.226~229 (2003)
3. Graves DT, "Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathology", J Dent Res, 85, pp.15~21 (2006)
4. Diabetes, "Committee on Research, Science and Therapy. American Academy of Periodontology", J Periodontol, 71, pp.664~678 (2007)
5. Pradhan AD, "Do atherosclerosis and type 2 diabetes share a common inflammatory basis", Eur Heart J, 23, pp.831~834 (2002)
6. Blüher M, "Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism", Exp Clin Endocrinol Diabetes, 113, pp.534~537 (2005)
7. Noack B, "Periodontal infections contribute to elevated systemic C-reactive protein level", J Periodontol, 72, pp.1221~1227 (2001)
8. Page RC, "The role of inflammatory mediators in the pathogenesis of periodontal disease", J Periodontal Res, 26(3), pp.230~242 (1991)
9. Craig RG, "Relationship of destructive periodontal disease to the acute-phase response", J Periodontol, 74, pp.1007~1016 (2003)
10. D’Aiuto F, "Periodontal disease and C-reactive protein-associated cardiovascular risk", J Periodontal Res, 39, pp.236~241 (2004)
11. Sorsa T, "Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases", Infect Immun, 60, pp.4491~4495 (1992)
12. Sternlicht MD, "How matrix metalloproteinases regulate cell behavior", Annu Rev Cell Dev Biol, 17, pp.463~516 (2001)
13. 박재완, "단순 만성 치주염 환자 및 2형 당뇨병환자의 만성 치주염 치은조직에서 IL-6, elastase 및 α1-PI의 발현 양상 비교", Journal of Periodontal & Implant Science, 37(5), pp.325~338 (2007), 대한치주과학회
14. Borden P, "Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases", Crit Rev Eukaryot Gene Expr, 7, pp.159~178 (1997)
15. Brinckerhoff CE, "Interstitial collagenases as markers of tumor progression", Clin Cancer Res, 6, pp.4823~4830 (2000)
16. Itoh Y, "MT1-MMP: a potent modifier of pericellular microenvironment", J Cell Physiol, 206, pp.1~8 (2006)
17. Stamenkovic I, "Extracellular matrix remodelling: the role of matrix metalloproteinases", J Pathol, 200, pp.448~464 (2003)
18. Brew K, "Tissue inhibitors of metalloproteinases: evolution, structure and function", Biochim Biophys Acta, 1477, pp.267~283 (2000)
19. Williamson RA, "Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP)", Biochem J, 268, pp.267~274 (1990)
20. Goldberg GI, "Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin", J Biol Chem, 267, pp.4583~4591 (1992)
21. Butler GS, "Atkinson SJ, Will H, Tamura T, Schade van Westrum S, et al. The TIMP2 membrane type 1 metalloproteinase “receptor” regulates the concentration and efficient activation of progelatinase A. A kinetic study", J Biol Chem, 273, pp.871~880 (1998)
22. Mühlemann HR, "Gingival sulcus bleeding: a leading symptom in initial gingivitis", Helv Odontol Acta, 15, pp.107~113 (1971)
23. Cho JY, "Expression and activity of human Na+", I- symporter in human glioma cells by adenovirus-mediated gene delivery, 2000, pp.7, 740~749
24. Tsai C, "Glycemic control of type 2 di abetes and severe periodontal disease in the US adult population", Community Dent Oral Epidemiol, 30, pp.182~192 (2002)
25. Cutler CW, "Association between periodontitis and hyperlipidemia: cause or effect", J Periodontol, 70, pp.1429~1434 (1999)
26. Vigushin DM, "Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease", J Clin Invest, 91, pp.1351~1357 (1993)
27. Mold C, "Regulation of complement activation by C-reactive protein", Immunopharmacology, 42, pp.23~30 (1999)
28. Ugarte H, "Procalcitonin used as a marker of infection in the intensive care unit", Crit Care Med, 27, pp.498~504 (1999)
29. Póvoa P, "C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study", Eur Respir J, 25, pp.804~812 (2005)
30. Hsueh WA, "Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease", Hypertension, 43, pp.297~305 (2004)
31. Zucker S, "Membrane type-matrix metalloproteinases (MT-MMP)", Curr Top Dev Biol, 54, pp.1~74 (2003)
32. Seiki M, "Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis", Cancer Sci, 94, pp.569~574 (2003)
33. Wu YI, "Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase", J Biol Chem, 279, pp.8278~8289 (2004)
34. Itoh Y, "MT1-MMP: an enzyme with multidimensional regulation", Trends Biochem Sci, 29, pp.285~289 (2004)
35. Song W, "Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size", Cardiovasc Diabetol, 5, pp.3~ (2006)
36. McLennan SV, "High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: possible role in mesangium accumulation", Diabetologia, 43, pp.642~648 (2000)

관련 논문AI추천